Our results did not reveal a link between high Ephrin B3 expression and poor patient survival whereas a high EphA2 expression was associated with improved survival (p=0.03) in this cohort of early stage NSCLC. The gene discussed is EFNB3; the disease is non-small cell lung carcinoma.